Takeda Pharmaceutical's immunoglobulin sales value FY 2018-2022
In fiscal year 2022, the sales value of immunoglobulin produced by Takeda Pharmaceutical Co., Ltd. accounted for approximately 522.2 billion Japanese yen, marking the highest sales value over a five-year period. In contrast, in fiscal year 2018, the sales value of immunoglobulin amounted to 73.5 billion yen. Throughout the period, the sales value demonstrated a steady uprising trend.